Clinical Development Solutions

Clinical Development Solutions (CDS) is a Contract Research Organization that focuses on addressing the clinical research needs of emerging life science companies. Founded in 2008 and headquartered in Canada, CDS specializes in providing strategic drug development, clinical trial, regulatory, pharmacovigilance, and quality assurance consulting to biotechnology, pharmaceutical, and medical device companies. CDS acknowledges the unique requirements of small companies and leverages its North American regulatory expertise to streamline clinical trials and interactions with the FDA and Health Canada. Their strategies are designed to accelerate the establishment of proof of concept and bring new products and indications to market faster. The company offers comprehensive clinical trial management services in Canada and the US, encompassing site selection, monitoring, quality assurance, project management, and post-market pharmacovigilance. Through their expertise, CDS aims to be a valuable collaborator for emerging life science or medical device companies. CDS secured its last investment in a Pre Seed Round from Genesys Venture on 01 January 2010. This investment reflects the trust and support of Genesys Venture in the potential of CDS to make a significant impact in the pharmaceutical industry.